Hydrochloric Acid

Hydrochloric Acid

SCHEMBL1978388

CCCCCCCCCCCCCC[N+](CC)(CCCCCCCCCCC)CCCCCCCCCCC.[Cl-]

nearest known ligand 0.83

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 6/20 0.83
SLC22A1 O15245 3/20 0.77
ALDH1A1 P00352 1/20 0.72
TP53 P04637 1/20 0.72
CYP3A4 P08684 1/20 0.72
ALOX15 P16050 1/20 0.72
TSHR P16473 1/20 0.72
ALOX12 P18054 1/20 0.72
SMN1; SMN2 Q16637 1/20 0.72
HIF1A Q16665 1/20 0.72
HSD17B10 Q99714 1/20 0.72
SLC22A2 O15244 1/20 0.71
HTT P42858 1/20 0.55
KMT2A Q03164 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5489691 1.00 DNM1 (0.83) DNM1SLC22A1ALDH1A1TP53CYP3A4
Hydrochloric Acid SCHEMBL9662861 1.00 DNM1 (0.83) DNM1SLC22A1ALDH1A1TP53CYP3A4
Hydrochloric Acid SCHEMBL5087269 1.00 DNM1 (0.83) DNM1SLC22A1ALDH1A1TP53CYP3A4
Hydrochloric Acid SCHEMBL5087270 1.00 DNM1 (0.83) DNM1SLC22A1ALDH1A1TP53CYP3A4
Hydrochloric Acid SCHEMBL10696275 1.00 DNM1 (0.83) DNM1SLC22A1ALDH1A1TP53CYP3A4
Hydrochloric Acid SCHEMBL10694987 1.00 DNM1 (0.83) DNM1SLC22A1ALDH1A1TP53CYP3A4
Hydrochloric Acid SCHEMBL782058 1.00 DNM1 (0.83) DNM1SLC22A1ALDH1A1TP53CYP3A4
Hydrochloric Acid SCHEMBL8735491 0.97 DNM1 (0.79) DNM1SLC22A1ALDH1A1TP53CYP3A4
SCHEMBL5309002 0.97 DNM1 (0.88) DNM1SLC22A1ALDH1A1TP53CYP3A4
SCHEMBL634319 0.97 DNM1 (0.88) DNM1SLC22A1ALDH1A1TP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230011640-A1 METHODS FOR RECOVERING ORGANIC SALTS FROM INDUSTRIAL PROCESS STREAMS CYTEC INDUSTRIES INC. (US) 2023-01-12 US claimed
EP-4073000-A1 METHODS FOR RECOVERING ORGANIC SALTS FROM INDUSTRIAL PROCESS STREAMS Cytec Industries, Inc. (US) 2022-10-19 EP claimed
WO-2021118938-A1 METHODS FOR RECOVERING ORGANIC SALTS FROM INDUSTRIAL PROCESS STREAMS CYTEC INDUSTRIES INC. (US) 2021-06-17 WO claimed
EP-3640212-A1 METHODS AND COMPOSITIONS FOR THE REMOVAL OF IMPURITIES AND WATER FROM THE BAYER PROCESS Cytec Technology Corp. (US) 2020-04-22 EP claimed
EP-2240409-B1 METHOD FOR THE REMOVAL OF IMPURITIES AND WATER FROM THE BAYER PROCESS CYTEC TECH CORP (US) 2019-11-20 EP claimed
US-8435411-B2 Methods and compositions for the removal of impurities from an impurity-loaded organic salt CYTEC TECHNOLOGY CORP. (US) 2013-05-07 US claimed
EP-2512614-A1 METHODS AND COMPOSITIONS FOR THE REMOVAL OF IMPURITIES FROM AN IMPURITY-LOADED IONIC LIQUID Cytec Technology Corp. (US) 2012-10-24 EP claimed
WO-2011081764-A1 METHODS AND COMPOSITIONS FOR THE REMOVAL OF IMPURITIES FROM AN IMPURITY-LOADED IONIC LIQUID CYTEC TECHNOLOGY CORP. (US) 2011-07-07 WO claimed
US-7972580-B2 Methods and compositions for the removal of impurities and water from the Bayer process CYTEC TECHNOLOGY CORP. (US) 2011-07-05 US claimed
US-20110140037-A1 METHODS AND COMPOSITIONS FOR THE REMOVAL OF IMPURITIES FROM AN IMPURITY-LOADED ORGANIC SALT CYTEC TECHNOLOGY CORP. (US) 2011-06-16 US claimed
EP-2240409-A1 METHODS AND COMPOSITIONS FOR THE REMOVAL OF IMPURITIES AND WATER FROM THE BAYER PROCESS CYTEC TECHNOLOGY CORP. (US) 2010-10-20 EP claimed
WO-2009086273-A1 METHODS AND COMPOSITIONS FOR THE REMOVAL OF IMPURITIES AND WATER FROM THE BAYER PROCESS CYTEC TECHNOLOGY CORP. (US) 2009-07-09 WO claimed
US-20090169447-A1 METHODS AND COMPOSITIONS FOR THE REMOVAL OF IMPURITIES AND WATER FROM THE BAYER PROCESS CYTEC TECHNOLOGY CORP 2009-07-02 US claimed
US-20230011640-A1 METHODS FOR RECOVERING ORGANIC SALTS FROM INDUSTRIAL PROCESS STREAMS CYTEC INDUSTRIES INC. (US) 2023-01-12 US disclosed
EP-4073000-A1 METHODS FOR RECOVERING ORGANIC SALTS FROM INDUSTRIAL PROCESS STREAMS Cytec Industries, Inc. (US) 2022-10-19 EP disclosed
EP-4065738-A1 A METHOD AND AN APPARATUS OF PURIFYING A BAYER PROCESS STREAM Rio Tinto Alcan International Limited (CA) 2022-10-05 EP disclosed
US-20110140037-A1 METHODS AND COMPOSITIONS FOR THE REMOVAL OF IMPURITIES FROM AN IMPURITY-LOADED ORGANIC SALT CYTEC TECHNOLOGY CORP. (US) 2011-06-16 US disclosed
EP-2240409-A1 METHODS AND COMPOSITIONS FOR THE REMOVAL OF IMPURITIES AND WATER FROM THE BAYER PROCESS CYTEC TECHNOLOGY CORP. (US) 2010-10-20 EP disclosed
WO-2009086273-A1 METHODS AND COMPOSITIONS FOR THE REMOVAL OF IMPURITIES AND WATER FROM THE BAYER PROCESS CYTEC TECHNOLOGY CORP. (US) 2009-07-09 WO disclosed
US-20090169447-A1 METHODS AND COMPOSITIONS FOR THE REMOVAL OF IMPURITIES AND WATER FROM THE BAYER PROCESS CYTEC TECHNOLOGY CORP 2009-07-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110140037-A1 METHODS AND COMPOSITIONS FOR THE REMOVAL OF IMPURITIES FROM AN IMPURITY-LOADED ORGANIC SALT OSTC, SLC10A6, SLC22A8 DNM1 1084/4885SLC22A1 194/4885ALDH1A1 2421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.